The Medical Journal of Australia
Episode 553: MJA Podcasts 2024 Episode 12: developments in treating kidney disease, with Professor Gopi Rangan
Apr 14, 2024
Professor Gopi Rangan, a nephrologist, discusses treating kidney disease, advice for GPs, patient support, and his busy specialist life. Topics cover managing kidney disease in vulnerable groups, Polycystic Kidney Disease, new medications like SGLT2 inhibitors, and balancing a military reservist role.
18:34
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Early identification through proactive screening is crucial for managing chronic kidney disease.
- New drug therapies like SGLT2 inhibitors provide promising avenues for slowing disease progression in kidney disease.
Deep dives
Prevalence and Risk Factors of Kidney Disease in Australia
Chronic kidney disease is a prevalent health issue in Australia, affecting approximately 6 million adults, with 2 million living with the condition. Early identification is crucial as kidney function can decline significantly before symptoms manifest. Risk groups include those with cardiovascular disease, diabetes, metabolic syndrome, First Australians, and certain racial groups, emphasizing the importance of proactive screening.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
